133 related articles for article (PubMed ID: 36920340)
1. ALKBH1 contributes to renal cell carcinoma progression by reducing N6-methyladenine of GPR137.
Li L; Zhu C; Xu Q; Xu S; Ye J; Xu D; Wang L; Gan S; Liu B; Tang C
Eur J Clin Invest; 2023 Jul; 53(7):e13986. PubMed ID: 36920340
[TBL] [Abstract][Full Text] [Related]
2. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
[TBL] [Abstract][Full Text] [Related]
3. DNA 6mA demethylase ALKBH1 regulates DDX18 expression to promote proliferation of human head and neck squamous cell carcinoma.
Guo C; Liu Z; Zhang H
Cell Oncol (Dordr); 2023 Aug; 46(4):1097-1111. PubMed ID: 36976498
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-339-5p suppresses the malignant development of gastric cancer via targeting ALKBH1.
Wang C; Huang Y; Zhang J; Fang Y
Exp Mol Pathol; 2020 Aug; 115():104449. PubMed ID: 32380054
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
[TBL] [Abstract][Full Text] [Related]
6. ALKBH1-mediated m
Chen W; Wang H; Mi S; Shao L; Xu Z; Xue M
Mol Oncol; 2023 Feb; 17(2):344-364. PubMed ID: 36550779
[TBL] [Abstract][Full Text] [Related]
7. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
8. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
[TBL] [Abstract][Full Text] [Related]
9. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
[TBL] [Abstract][Full Text] [Related]
10. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O
Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176
[TBL] [Abstract][Full Text] [Related]
11. ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease.
Ouyang L; Su X; Li W; Tang L; Zhang M; Zhu Y; Xie C; Zhang P; Chen J; Huang H
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34003800
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
[TBL] [Abstract][Full Text] [Related]
13. Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.
Kumagai S; Ishibashi K; Kataoka M; Oguro T; Kiko Y; Yanagida T; Aikawa K; Kojima Y
Cancer Sci; 2016 Nov; 107(11):1632-1641. PubMed ID: 27589337
[TBL] [Abstract][Full Text] [Related]
14. ALKBH1 promotes lung cancer by regulating m6A RNA demethylation.
Li H; Zhang Y; Guo Y; Liu R; Yu Q; Gong L; Liu Z; Xie W; Wang C
Biochem Pharmacol; 2021 Jul; 189():114284. PubMed ID: 33068553
[TBL] [Abstract][Full Text] [Related]
15. N
Diao LT; Xie SJ; Yu PJ; Sun YJ; Yang F; Tan YY; Tao S; Hou YR; Zheng LL; Xiao ZD; Zhang Q
Exp Cell Res; 2021 Mar; 400(2):112492. PubMed ID: 33529710
[TBL] [Abstract][Full Text] [Related]
16. LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG.
Pu Y; Dong Z; Xia Y; Zhang M; Song J; Han J; Liu H
Biomed Pharmacother; 2019 Oct; 118():109382. PubMed ID: 31545257
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
[TBL] [Abstract][Full Text] [Related]
18. Praeruptorin B Mitigates the Metastatic Ability of Human Renal Carcinoma Cells through Targeting CTSC and CTSV Expression.
Lin CL; Hung TW; Ying TH; Lin CJ; Hsieh YH; Chen CM
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331211
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
20. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
